Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 19, 2018
Lonza Pharma & Biotech has opened its Collaborative Innovation Center (CIC) in the Haifa Life Science Park, Israel.
read more
Lonza is opening a dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies.
read more
Wednesday, August 26, 2026
Lonza has appointed Samanta Cimitan as chief commercial officer, senior vice president and a member of its Extended Executive Committee, creating a role intended to strengthen customer engagement and establish a unified commercial approach across the...
read more
Tuesday, October 13, 2026
Lonza has signed an exclusive license agreement with Qurient to use the Korean biotechnology company’s cyclin-dependent kinase 7 inhibitors in dual-payload antibody-drug conjugates, adding a new technology to its cancer drug development and ...
read more
Wednesday, October 07, 2020
Lonza Bioscience has announced the commercial release of the PyroCell™ MAT System, a sustainable and reliable solution for in vitro pyrogen testing.
read more
Lonza has launched a rapid custom media prototyping service designed to help life sciences customers accelerate early-stage development of cell culture media formulations.
read more
Lonza announced the launch of its new Design2Optimize™ platform to enhance process development and manufacturing of small molecule APIs.
read more
Lonza announced the launch of its Media Development Lab at its Singapore site. The offering aims to support bioprocessing customers in optimizing their media formulations and facilitating a smooth transition to GMP manufacturing, helping reduce scale...
read more
Lonza announced the launch of its AI-enabled Route Scouting Service offering. The offering aims to streamline synthetic route identification for novel APIs by combining Lonza’s global chemical supply chain intelligence and in-house expertise with AI ...
read more
Lonza announced its membership in the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS). Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation...
read more
Wednesday, October 26, 2022
Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced its participation in the GENEGUT project to develop an innovative functional capsule-based delivery solution for therapies targeting ...
read more
Lonza announced new investments in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China. The investments, totaling over $22 million, will allow Lonza to provide a smoother transition from small-scale to...
read more
Lonza expanded the range of particle engineering services offered by its Monteggio (CH) site through the introduction of X-ray powder diffraction (XRPD).
read more
Lonza has introduced an enhanced product line aimed at tackling concerns around bias during blinded clinical trials.
read more
Lonza, a CDMO partner to the biopharma industry, announced the extension of its collaboration with a major biopharmaceutical partner for the commercial-scale manufacture of monoclonal antibodies, under a long-term agreement. At scale, and following ...
read more